Kevin E. Noonan, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP to Speak at The Knowledge Group’s Patent Protection in Life Sciences
The Knowledge Group, the leading producer of regulatory focused webcasts, has announced today that Kevin E. Noonan, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP will speak at its webcast entitled, “Patent Protection in Life Sciences: Creative Approaches to Safeguard Your Innovations.” This event is scheduled for September 27, 2023, from 12:00 pm to 1:00 pm (ET).
- (1888PressRelease) August 30, 2023 - The Knowledge Group, the leading producer of regulatory focused webcasts, has announced today that Kevin E. Noonan, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP will speak at its webcast entitled, “Patent Protection in Life Sciences: Creative Approaches to Safeguard Your Innovations.” This event is scheduled for September 27, 2023, from 12:00 pm to 1:00 pm (ET).
For further details, please visit:
https://knowledgewebcasts.com/know-portfolio/patent-protection-in-life-sciences-cle-2023/
About Kevin E. Noonan, Ph.D.
KEVIN E. NOONAN, Ph.D. is a partner with McDonnell Boehnen Hulbert & Berghoff LLP, and co-chair of the firm’s Biotechnology and Pharmaceuticals practice group. He represents start-up companies and universities in patent portfolio development and licensing, provided counsel for private placement investments and initial public offerings, and represented major U.S. pharmaceutical companies in patent interferences, patent prosecution, interferences, patent infringement litigation, and in obtaining patent term extension for valuable drug products. Dr. Noonan is a founding author of the biotechnology patent weblog, PatentDocs (www.patentdocs.org). Dr. Noonan received a Bachelor of Science degree in biochemistry from the State University of New York/Stony Brook a Ph.D. in molecular biology from Princeton University, and graduated cum laude from the John Marshall Law School.
About McDonnell Boehnen Hulbert & Berghoff LLP
McDonnell Boehnen Hulbert & Berghoff LLP (MBHB) provides creative, pragmatic IP business solutions for Fortune 100 companies, mid-size companies, startups, and academic institutions. Our clients entrust their legal issues and plans with knowledgeable, principled attorneys and professionals who have their best business interests in mind. In the U.S. and abroad, clients engage us to secure and enforce their intellectual property rights, from navigating patent office procedures to litigating complex infringement actions. We provide effective and service-oriented representation on a case-by-case basis, undertaking each challenge with a full understanding of our client’s business plan and the ways in which our services help them reach their goals. Regardless of our role, we never lose sight of our clients’ business objectives. For more information, visit mbhb.com.
Event Summary
Patent litigation remains prolific in the life sciences industry as ensuring protection becomes more challenging and complex due to the involvement of technologies. Some issues plaguing patent owners and intellectual property (IP) lawyers concern the Section 101 jurisprudence related to innovations in the life sciences industry. Moreover, landmark cases like Amgen Inc. v. Sanofi continue to shape the patent landscape, posing profound impacts on invention enablement. These and other developments continue to pose risks that practitioners should be wary of. Canadian jurisprudence deals with similar issues and in some cases, patent practice diverges between the US and Canada.
Listen as experienced patent attorneys Melanie Szweras (Bereskin & Parr LLP) and Kevin E. Noonan, Ph.D. (McDonnell Boehnen Hulbert & Berghoff LLP) provide a comprehensive discussion of the latest trends and challenges in protecting patents in the life science sector. Speakers, among other things, will offer practical tips and strategies for navigating this dynamic regulatory environment.
Key topics include:
• Life Science Patents: Latest Regulatory Developments in the US and Canada
• Current Challenges and Regulatory Issues Faced by Patent Owners and IP Lawyers
• Notable Cases in the US and Canada
• What Lies Ahead
About The Knowledge Group
Founded in November 2006, The Knowledge Group has been at the forefront of providing quality continuing education programs for lawyers, accountants, financial executives, risk and compliance specialists, human resources professionals, technology officers, and business consultants in a wide range of industries.
The Knowledge Group strives to be the best-in-class provider of continuing education by bringing forth relevant content you can’t get anywhere else.
Contact:
Therese Lumbao
Director, Member Services
The Knowledge Group, LLC
info ( @ ) theknowledgegroup dot org
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam